| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1097-0142(19950901)76:5<743::AID-CNCR2820760506>3.0.CO;2-V |
| P698 | PubMed publication ID | 8625175 |
| P2093 | author name string | Kobayashi K | |
| Oka H | |||
| Yamamoto S | |||
| Kim SR | |||
| Tango T | |||
| Kuroki T | |||
| Monna T | |||
| Harihara S | |||
| Marumo T | |||
| P2860 | cites work | Inhibition by Xiao-chai-hu-tang (TJ-9) of Development of Hepatic Foci Induced by N-Nitrosomorpholine in Sprague-Dawley Rats | Q54965760 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 743-749 | |
| P577 | publication date | 1995-09-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). | |
| P478 | volume | 76 |
| Q35962702 | A Complex Multiherbal Regimen Based on Ayurveda Medicine for the Management of Hepatic Cirrhosis Complicated by Ascites: Nonrandomized, Uncontrolled, Single Group, Open-Label Observational Clinical Study |
| Q93357166 | A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins |
| Q51930324 | A computational approach to botanical drug design by modeling quantitative composition-activity relationship. |
| Q53347425 | A long-term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients. |
| Q35190676 | Alternative medicines and the liver |
| Q33630593 | Anti-tumor activity of four Ayurvedic herbs in Dalton lymphoma ascites bearing mice and their short-term in vitro cytotoxicity on DLA-cell-line |
| Q47320163 | Anticancer effect of a Kampo preparation Daikenchuto. |
| Q33904514 | Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines |
| Q35047714 | Antiviral activity of Acacia nilotica against Hepatitis C Virus in liver infected cells |
| Q30479629 | Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma |
| Q44916075 | Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis |
| Q37612137 | Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide population-based cohort study |
| Q89947328 | Astragaloside IV Induces Apoptosis, G1-Phase Arrest and Inhibits Anti-apoptotic Signaling in Hepatocellular Carcinoma |
| Q38250325 | Autophagic effects of Chaihu (dried roots of Bupleurum Chinense DC or Bupleurum scorzoneraefolium WILD). |
| Q40751278 | Baicalin induces apoptosis via mitochondrial pathway as prooxidant |
| Q40762945 | Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest |
| Q30748992 | Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials |
| Q32028457 | Changes in titers of antimitochondrial and antinuclear antibodies during the course of primary biliary cirrhosis |
| Q92118677 | Characterizing the Neuroprotective Effects of S/B Remedy (Scutellaria baicalensis Georgi and Bupleurum scorzonerifolfium Willd) in Spinal Cord Injury |
| Q40474560 | Chemoprevention against hepatocellular carcinoma of Cornus officinalis in vitro. |
| Q34536138 | Chemoprevention of hepatocellular carcinoma: concept, progress and perspectives. |
| Q30661938 | Chinese medicinal herbs for chronic hepatitis B. |
| Q43000078 | Clinical characteristics of patients with chronic hepatitis C showing biochemical remission, without hepatitis C virus eradication, as a result of interferon therapy. The Osaka Liver Disease Study Group |
| Q36034906 | Complementary and alternative medicine in the treatment of chronic liver disease |
| Q40997459 | Cordyceps sinensis increases the expression of major histocompatibility complex class II antigens on human hepatoma cell line HA22T/VGH cells |
| Q26775055 | Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects |
| Q38121537 | Current understanding on antihepatocarcinoma effects of xiao chai hu tang and its constituents |
| Q40299754 | Effects of Scutellaria baicalensis Georgi on macrophage-hepatocyte interaction through cytokines related to growth control of murine hepatocytes |
| Q42465673 | Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats |
| Q43949551 | Effects of flavonoids isolated from Scutellariae radix on cytochrome P-450 activities in human liver microsomes |
| Q40816875 | Effects of four Indian medicinal herbs on Isoniazid-, Rifampicin- and Pyrazinamide-induced hepatic injury and immunosuppression in guinea pigs |
| Q77897841 | Effects of qing fei tang (TJ-90) on aspiration pneumonia in mice |
| Q43787075 | Effects of the Japanese herbal medicine 'Sho-saiko-to' as a cytokine inducer |
| Q64112544 | Emodin inhibits colon cancer by altering BCL-2 family proteins and cell survival pathways |
| Q50196951 | Evaluation preparation technology of Xiaochaihu granules using fingerprint-peak pattern matching. |
| Q42322923 | Evidence-Based TAM Classic Herbal Formula: From Myth to Science. |
| Q40172999 | Glycyrrhizin injection therapy prevents hepatocellular carcinogenesis in patients with interferon-resistant active chronic hepatitis C. |
| Q41619963 | Hepatitis C virus infection in the elderly. Epidemiology, prophylaxis and optimal treatment |
| Q93930900 | Hepatocellular carcinoma |
| Q35628112 | Hepatocellular carcinoma: updates in primary prevention |
| Q34007767 | Hepatotoxicity of botanicals |
| Q35117008 | Herbal medicine and hepatocellular carcinoma: applications and challenges |
| Q33739196 | Herbal products for liver diseases: a therapeutic challenge for the new millennium |
| Q21284956 | Herbal products: benefits, limits, and applications in chronic liver disease |
| Q26992265 | Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders |
| Q37211025 | Herbs and other botanicals in cancer patient care |
| Q91656349 | Herbs to treat liver diseases: More than placebo? |
| Q74501896 | In vitro effects of sho-saiko-to on production of granulocyte colony-stimulating factor by mononuclear cells from patients with chronic hepatitis C |
| Q42990892 | Inflammation in background cirrhosis evokes malignant progression in HCC development from HCV-associated liver cirrhosis |
| Q44036823 | Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats. |
| Q40428837 | Inhibitory effects of herbal drugs on the growth of human ovarian cancer cell lines through the induction of apoptosis |
| Q33923422 | Inhibitory effects of sudanese medicinal plant extracts on hepatitis C virus (HCV) protease |
| Q31970467 | Inhibitory effects of the herbal medicine Sho-saiko-to (TJ-9) on cell proliferation and procollagen gene expressions in cultured rat hepatic stellate cells |
| Q47424080 | Integration of woodchuck hepatitis and N-myc rearrangement determine size and histologic grade of hepatic tumors |
| Q61440972 | Interferon and hepatocellular carcinoma |
| Q71567137 | Issues for the FDA |
| Q74530378 | Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression |
| Q73572054 | Modulation of lung local immune responses by oral administration of a herbal medicine Sho-saiko-to |
| Q51742153 | Multiobjective optimization on antiplatelet effects of three components combination by quantitative composition-activity relationship modeling and weighted-sum method. |
| Q37148781 | Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer |
| Q45401274 | Overexpressed cyclo-oxygenase-2 in the background liver is associated with the clinical course of hepatitis C virus-related cirrhosis patients after curative surgery for hepatocellular carcinoma |
| Q34536537 | Panax ginseng: a role in cancer therapy? |
| Q28366616 | Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma |
| Q36579871 | Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use. |
| Q43162201 | Phytochemicals in hepatocellular cancer prevention |
| Q45747501 | Potent synergistic effect of sho-saiko-to, a herbal medicine, during vaccine therapy in a murine model of hepatitis B virus carrier |
| Q40172995 | Potential role of vitamin K(2) as a chemopreventive agent against hepatocellular carcinoma |
| Q26853520 | Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy |
| Q28272678 | Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges |
| Q36946710 | Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress |
| Q47815301 | Qualitative and quantitative simultaneous determination of six marker compounds in Soshiho-tang by HPLC-DAD-ESI-MS. |
| Q35097371 | Radical causes of cancer. |
| Q39358751 | Radix Bupleuri: A Review of Traditional Uses, Botany, Phytochemistry, Pharmacology, and Toxicology. |
| Q34365919 | Review article: herbal treatment in gastrointestinal and liver disease--benefits and dangers |
| Q21135574 | Risk of liver injury associated with Chinese herbal products containing radix bupleuri in 639,779 patients with hepatitis B virus infection |
| Q64903808 | Saikosaponin-d Suppresses COX2 Through p-STAT3/C/EBPβ Signaling Pathway in Liver Cancer: A Novel Mechanism of Action. |
| Q33576349 | Saikosaponins induced hepatotoxicity in mice via lipid metabolism dysregulation and oxidative stress: a proteomic study |
| Q74132568 | Semi-quantitative analysis of cytokine mRNA expression induced by the herbal medicine Sho-saiko-to (TJ-9) using a Gel Doc system |
| Q33965800 | Several Culinary and Medicinal Herbs Are Important Sources of Dietary Antioxidants |
| Q40145456 | Sho-saiko-to (Xiao-Chai-Hu-Tang) and crude saikosaponins inhibit hepatitis B virus in a stable HBV-producing cell line |
| Q33888088 | Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma |
| Q34056782 | Shosaiko-to and other Kampo (Japanese herbal) medicines: a review of their immunomodulatory activities |
| Q78228848 | Strong antiproliferative effects of baicalein in cultured rat hepatic stellate cells |
| Q37146317 | Study designs of randomized controlled trials not based on Chinese medicine theory are improper |
| Q47396881 | Studying Traditional Chinese Medicine |
| Q33555799 | Suppression of E-cadherin mediates gallotannin induced apoptosis in Hep G2 hepatocelluar carcinoma cells |
| Q47335559 | Synergy in traditional Chinese medicine |
| Q37314629 | TJ-41 Induces Apoptosis and Potentiates the Apoptotic Effects of 5-FU in Breast Cancer Cell Lines |
| Q39786097 | The effect of Scutellaria baicalensis on the signaling network in hepatocellular carcinoma cells |
| Q43769941 | The effects of a Chinese herb formula, anti-cancer number one (ACNO), on NK cell activity and tumor metastasis in rats |
| Q44720807 | The in-vivo effects of sho-saiko-to, a traditional Chinese herbal medicine, on two cytochrome P450 enzymes (1A2 and 3A) and xanthine oxidase in man. |
| Q53444006 | The long term efficacy of glycyrrhizin in chronic hepatitis C patients. |
| Q34571849 | The role of complementary and alternative medicine in cancer |
| Q34451466 | The role of plant-derived drugs and herbal medicines in healthcare |
| Q34554574 | The use of selected nutrition supplements and complementary and alternative medicine in liver disease |
| Q37055147 | Therapeutic applications of herbal medicines for cancer patients |
| Q37891168 | Therapeutic effects of the oriental herbal medicine Sho-saiko-to on liver cirrhosis and carcinoma |
| Q98946921 | Traditional Chinese medicine as supportive care for the management of liver cancer: Past, present, and future |
| Q35626771 | Traditional Chinese medicine for prevention and treatment of hepatocarcinoma: From bench to bedside |
| Q38038685 | Traditional Japanese herbal (kampo) medicines and treatment of ocular diseases: a review. |
| Q35091257 | Treatment strategies for hepatocellular carcinoma in cirrhosis. |
| Q47182697 | Trusting in traditional cures |
| Q33793052 | Viral hepatitis and hepatocellular carcinoma prevention strategy in Japan |
| Q37936095 | Western and Chinese medicine in oncology and hematology |
| Q35076822 | Xiaochaihu Decoction attenuates the vicious circle between the oxidative stress and the ALP inactivation through LPS-catecholamines interactions in gut, liver and brain during CCI4+ethanol-induced mouse HCC. |
| Q57945456 | ‘Alternative cancer cures’: looking for common ground |
Search more.